Waratah Capital Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-70,149
| Closed | -$7.95M | – | 111 |
|
|
2024
Q2 | $7.95M | Buy |
70,149
+17,570
| +33% | +$1.99M | 0.29% | 59 |
|
|
2024
Q1 | $7.29M | Sell |
52,579
-54,049
| -51% | -$7.5M | 0.22% | 66 |
|
|
2023
Q4 | $13.2M | Buy |
106,628
+44,221
| +71% | +$5.49M | 0.26% | 38 |
|
|
2023
Q3 | $5.82M | Sell |
62,407
-25,709
| -29% | -$2.4M | 0.08% | 66 |
|
|
2023
Q2 | $11.3M | Sell |
88,116
-12,021
| -12% | -$1.54M | 0.22% | 44 |
|
|
2023
Q1 | $11.6M | Buy |
100,137
+75,734
| +310% | +$8.8M | 0.26% | 50 |
|
|
2022
Q4 | $2.76M | Buy |
+24,403
| New | +$2.76M | 0.05% | 75 |
|
|
2022
Q2 | – | Sell |
-7,376
| Closed | -$943K | – | 159 |
|
|
2022
Q1 | $943K | Buy |
+7,376
| New | +$943K | 0.01% | 129 |
|
|
2019
Q4 | – | Sell |
-40,684
| Closed | -$1.52M | – | 142 |
|
|
2019
Q3 | $1.52M | Buy |
+40,684
| New | +$1.52M | 0.17% | 91 |
|